The University of Chicago Header Logo

Connection

Gaurav Upadhyay to Aged

Back to Details
This is a "connection" page, showing publications Gaurav Upadhyay has written about Aged.
Gaurav Upadhyay
Connection Strength
0.991
Aged
  1. Clinical outcomes of conduction system pacing compared to biventricular pacing in patients with mid-range ejection fraction. J Interv Card Electrophysiol. 2025 Jan; 68(1):111-116.
    View in: PubMed
    Score: 0.065
  2. A Revised Definition of Left Bundle Branch Block Using Time to Notch in Lead I. JAMA Cardiol. 2024 May 01; 9(5):449-456.
    View in: PubMed
    Score: 0.064
  3. Predicting Malignant Ventricular Arrhythmias Using Real-Time Remote Monitoring. J Am Coll Cardiol. 2023 03 14; 81(10):949-961.
    View in: PubMed
    Score: 0.059
  4. Population-Level Impact of the Guidelines Update on Patient Selection and Outcomes After Cardiac Resynchronization Therapy. JACC Clin Electrophysiol. 2022 05; 8(5):651-661.
    View in: PubMed
    Score: 0.055
  5. His Corrective Pacing or Biventricular Pacing for Cardiac Resynchronization in Heart Failure. J Am Coll Cardiol. 2019 07 09; 74(1):157-159.
    View in: PubMed
    Score: 0.045
  6. Intracardiac Delineation of Septal Conduction in Left Bundle-Branch Block Patterns. Circulation. 2019 04 16; 139(16):1876-1888.
    View in: PubMed
    Score: 0.045
  7. Impact of Atrial Fibrillation Ablation on Recurrent Hospitalization: A Nationwide Cohort Study. JACC Clin Electrophysiol. 2019 03; 5(3):330-339.
    View in: PubMed
    Score: 0.044
  8. Assessing mitral regurgitation in the prediction of clinical outcome after cardiac resynchronization therapy. Heart Rhythm. 2015 Jun; 12(6):1201-8.
    View in: PubMed
    Score: 0.034
  9. Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies. J Am Coll Cardiol. 2008 Oct 07; 52(15):1239-46.
    View in: PubMed
    Score: 0.022
  10. Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN Trial. Circ Arrhythm Electrophysiol. 2024 Dec; 17(12):e012836.
    View in: PubMed
    Score: 0.017
  11. Electrophysiological predictors of susceptible atrial substrate for the onset and recurrence of atrial fibrillation. J Interv Card Electrophysiol. 2025 Apr; 68(3):635-642.
    View in: PubMed
    Score: 0.017
  12. Quality of Life in Subcutaneous or Transvenous Implantable Cardioverter-Defibrillator Patients: A Secondary Analysis of the PRAETORIAN Trial. Circ Cardiovasc Qual Outcomes. 2024 11; 17(11):e010822.
    View in: PubMed
    Score: 0.017
  13. Multicenter Hemodynamic Assessment of the LOT-CRT Strategy: When Does Combining Left Bundle Branch Pacing and Coronary Venous Pacing Enhance Resynchronization?: Primary Results of the CSPOT Study. Circ Arrhythm Electrophysiol. 2024 Nov; 17(11):e013059.
    View in: PubMed
    Score: 0.016
  14. Conduction system pacing compared with biventricular pacing for cardiac resynchronization therapy in patients with heart failure and mildly reduced left ventricular ejection fraction: Results from International Collaborative LBBAP Study (I-CLAS) Group. Heart Rhythm. 2025 Jun; 22(6):1512-1522.
    View in: PubMed
    Score: 0.016
  15. Rate-Dependent Pacemap Matching in Scar-Related Ventricular Tachycardia: Impact of "TR Fusion" Phenomenon. JACC Clin Electrophysiol. 2024 Oct; 10(10):2132-2144.
    View in: PubMed
    Score: 0.016
  16. Association between COVID-19 vaccination and atrial arrhythmias in individuals with cardiac implantable electronic devices. J Cardiovasc Electrophysiol. 2024 Sep; 35(9):1828-1836.
    View in: PubMed
    Score: 0.016
  17. Predictors of Shock-Reduction Programming and Its Impact on Implantable Cardioverter-Defibrillator Therapies and Mortality: The CERTITUDE Registry. J Am Heart Assoc. 2024 Aug 06; 13(15):e034500.
    View in: PubMed
    Score: 0.016
  18. Procedural and Intermediate-term Results of the Electroanatomical-guided Cardioneuroablation for the Treatment of Supra-Hisian Second- or Advanced-degree Atrioventricular Block: the PIRECNA multicentre registry. Europace. 2024 Jul 02; 26(7).
    View in: PubMed
    Score: 0.016
  19. Septal venous channel perforation during left bundle branch area pacing: a prospective study. Europace. 2024 Jun 03; 26(6).
    View in: PubMed
    Score: 0.016
  20. Machine learning for prediction of ventricular arrhythmia episodes from intracardiac electrograms of automatic implantable cardioverter-defibrillators. Heart Rhythm. 2024 Nov; 21(11):2295-2302.
    View in: PubMed
    Score: 0.016
  21. Rescue left bundle branch area pacing in coronary venous lead failure or nonresponse to biventricular pacing: Results from International LBBAP Collaborative Study Group. Heart Rhythm. 2022 08; 19(8):1272-1280.
    View in: PubMed
    Score: 0.014
  22. Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial. Circulation. 2022 02; 145(5):321-329.
    View in: PubMed
    Score: 0.013
  23. Implantation of cardiac electronic devices in active COVID-19 patients: Results from an international survey. Heart Rhythm. 2022 02; 19(2):206-216.
    View in: PubMed
    Score: 0.013
  24. Atypical pathogens associated with cardiac implantable electronic device infections. Pacing Clin Electrophysiol. 2021 Sep; 44(9):1549-1561.
    View in: PubMed
    Score: 0.013
  25. Double loop ventricular tachycardia activation patterns with single loop mechanisms: Asymmetric entrainment responses during "pseudo-figure-of-eight" reentry. Heart Rhythm. 2021 09; 18(9):1548-1556.
    View in: PubMed
    Score: 0.013
  26. Spatial and transmural properties of the reentrant ventricular tachycardia circuit in arrhythmogenic right ventricular cardiomyopathy: Simultaneous epicardial and endocardial recordings. Heart Rhythm. 2021 06; 18(6):916-925.
    View in: PubMed
    Score: 0.013
  27. Prognostic value of cardiac magnetic resonance septal late gadolinium enhancement patterns for periaortic ventricular tachycardia ablation: Heterogeneity of the anteroseptal substrate in nonischemic cardiomyopathy. Heart Rhythm. 2021 04; 18(4):579-588.
    View in: PubMed
    Score: 0.013
  28. Circuit Determinants of Ventricular Tachycardia Cycle Length: Characterization of Fast and Unstable Human Ventricular Tachycardia. Circulation. 2021 01 19; 143(3):212-226.
    View in: PubMed
    Score: 0.013
  29. Left ventricular summit arrhythmias with an abrupt V3 transition: Anatomy of the aortic interleaflet triangle vantage point. Heart Rhythm. 2021 01; 18(1):10-19.
    View in: PubMed
    Score: 0.012
  30. Characterization of Lead Adherence Using Intravascular Ultrasound to Assess Difficulty of Transvenous Lead Extraction. Circ Arrhythm Electrophysiol. 2020 08; 13(8):e007726.
    View in: PubMed
    Score: 0.012
  31. Periaortic ventricular tachycardia in structural heart disease: Evidence of localized reentrant mechanisms. Heart Rhythm. 2020 08; 17(8):1271-1279.
    View in: PubMed
    Score: 0.012
  32. Simultaneous Endocardial and Epicardial Delineation of 3D Reentrant Ventricular Tachycardia. J Am Coll Cardiol. 2020 03 03; 75(8):884-897.
    View in: PubMed
    Score: 0.012
  33. High-Density Grid Catheter for Detailed Mapping of Sinus Rhythm and Scar-Related Ventricular Tachycardia: Comparison With a Linear Duodecapolar Catheter. JACC Clin Electrophysiol. 2020 03; 6(3):311-323.
    View in: PubMed
    Score: 0.012
  34. Targeted Ablation of Ventricular Tachycardia Guided by Wavefront Discontinuities During Sinus Rhythm: A New Functional Substrate Mapping Strategy. Circulation. 2019 10 22; 140(17):1383-1397.
    View in: PubMed
    Score: 0.012
  35. The effects of cardiac resynchronization therapy on left ventricular and mitral valve geometry and secondary mitral regurgitation in patients with left bundle branch block. Echocardiography. 2019 08; 36(8):1450-1458.
    View in: PubMed
    Score: 0.012
  36. Prevalence and predictors of atrial arrhythmias in patients with sinus node dysfunction and atrial pacing. J Interv Card Electrophysiol. 2018 Dec; 53(3):365-371.
    View in: PubMed
    Score: 0.011
  37. Impact of high-grade atrioventricular block and cumulative frequent pacing on atrial arrhythmias. Pacing Clin Electrophysiol. 2018 09; 41(9):1158-1164.
    View in: PubMed
    Score: 0.011
  38. Wide complex tachycardia transitioning between 2 morphologies: What is the mechanism? J Cardiovasc Electrophysiol. 2018 09; 29(9):1327-1329.
    View in: PubMed
    Score: 0.011
  39. Effects of cardiac resynchronization therapy after inferior myocardial infarction on secondary mitral regurgitation and mitral valve geometry. Pacing Clin Electrophysiol. 2018 02; 41(2):114-121.
    View in: PubMed
    Score: 0.010
  40. High-resolution mapping of the triangle of Koch: Spatial heterogeneity of fast pathway atrionodal connections. Heart Rhythm. 2018 03; 15(3):421-429.
    View in: PubMed
    Score: 0.010
  41. Impact of cardiac resynchronization therapy on mitral valve apparatus geometry and clinical outcomes in patients with secondary mitral regurgitation. Echocardiography. 2017 Nov; 34(11):1561-1567.
    View in: PubMed
    Score: 0.010
  42. Characterization of Ventricular Tachycardia After Left Ventricular Assist Device Implantation as Destination Therapy: A Single-Center Ablation Experience. JACC Clin Electrophysiol. 2017 12 11; 3(12):1412-1424.
    View in: PubMed
    Score: 0.010
  43. Permanent His-bundle pacing for cardiac resynchronization therapy: Initial feasibility study in lieu of left ventricular lead. Heart Rhythm. 2017 09; 14(9):1353-1361.
    View in: PubMed
    Score: 0.010
  44. Entrainment of ventricular tachycardia: Is the pacing site in or out? Heart Rhythm. 2016 12; 13(12):2399-2400.
    View in: PubMed
    Score: 0.010
  45. Renal Response in Patients with Chronic Kidney Disease Predicts Outcome Following Cardiac Resynchronization Therapy. Pacing Clin Electrophysiol. 2015 Oct; 38(10):1192-200.
    View in: PubMed
    Score: 0.009
  46. Progressive ventricular dysfunction among nonresponders to cardiac resynchronization therapy: baseline predictors and associated clinical outcomes. Heart Rhythm. 2014 Nov; 11(11):1991-8.
    View in: PubMed
    Score: 0.008
  47. Does prior valve surgery change outcome in patients treated with cardiac resynchronization therapy? J Cardiovasc Electrophysiol. 2014 Nov; 25(11):1206-13.
    View in: PubMed
    Score: 0.008
  48. Pre-capillary pulmonary hypertension and right ventricular dilation predict clinical outcome in cardiac resynchronization therapy. JACC Heart Fail. 2014 Jun; 2(3):230-7.
    View in: PubMed
    Score: 0.008
  49. Device-measured physical activity versus six-minute walk test as a predictor of reverse remodeling and outcome after cardiac resynchronization therapy for heart failure. Am J Cardiol. 2014 May 01; 113(9):1523-8.
    View in: PubMed
    Score: 0.008
  50. Impact of myocardial viability and left ventricular lead location on clinical outcome in cardiac resynchronization therapy recipients with ischemic cardiomyopathy. J Cardiovasc Electrophysiol. 2014 May; 25(5):507-513.
    View in: PubMed
    Score: 0.008
  51. Usefulness and consequences of cardiac resynchronization therapy in dialysis-dependent patients with heart failure. Am J Cardiol. 2013 Nov 15; 112(10):1625-31.
    View in: PubMed
    Score: 0.008
  52. QRS morphology, left ventricular lead location, and clinical outcome in patients receiving cardiac resynchronization therapy. Eur Heart J. 2013 Aug; 34(29):2252-62.
    View in: PubMed
    Score: 0.007
  53. The anatomic and electrical location of the left ventricular lead predicts ventricular arrhythmia in cardiac resynchronization therapy. Heart Rhythm. 2013 May; 10(5):668-75.
    View in: PubMed
    Score: 0.007
  54. Right ventricular lead adjustment in cardiac resynchronization therapy and acute hemodynamic response: a pilot study. J Interv Card Electrophysiol. 2013 Apr; 36(3):223-31.
    View in: PubMed
    Score: 0.007
  55. Electrical delay in apically positioned left ventricular leads and clinical outcome after cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2013 Feb; 24(2):182-7.
    View in: PubMed
    Score: 0.007
  56. Usefulness of hemoglobin A(1c) to predict outcome after cardiac resynchronization therapy in patients with diabetes mellitus and heart failure. Am J Cardiol. 2012 Sep 01; 110(5):683-8.
    View in: PubMed
    Score: 0.007
  57. Multidisciplinary care of patients receiving cardiac resynchronization therapy is associated with improved clinical outcomes. Eur Heart J. 2012 Sep; 33(17):2181-8.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.